ABSTRACT

This book introduces charnolophagy (CP) as energy-driven, lysosomal-dependent mitochondrial inclusion-specific pleomorphic Charnoly body (CB) autophagy (ATG) involving free radical-induced Ca2+ dyshomeostasis, ΔΨ collapse, and ATP depletion in congenital diseases, pressure ulcers, metabolic diseases, hepatic diseases, diabetes, obesity, inflammatory diseases, musculoskeletal diseases, sarcopenia, cachexia, respiratory diseases, gastrointestinal diseases, hyperlipidemia, skin and hair diseases, pulmonary diseases, cardiovascular diseases, renal diseases, sepsis-induced multi-organ failure, reproductive diseases, inflammatory diseases, ophthalmic diseases, neurodegenerative diseases, drug addiction, aging, microbial (including COVID-19) infections, and belligerent malignancies implicated in early morbidity and mortality and disease-specific spatiotemporal, targeted, safe, and effective evidence-based personalized theranostic charnolopharmacotherapeutics to cure them. Basic DRESS and GELS principles, nanoparticles to cure chronic multidrug-resistant (MDR) diseases, antioxidants as free radical scavengers, CB antagonists, CP regulators, and CS stabilizers to curb CB molecular pathogenesis (CBMP) are described for better quality of life and longevity. Specific guidelines for environmental protection and preservation of zoological and botanical species at the verge of extinction, Triple "I" Hypothesis for mitochondrial quality control, and transcriptional regulation of CSexR and CSendoR to cure chronic diseases are presented. Novel CP index is introduced to evaluate MDR malignancies and other chronic diseases. WHO, CDC, FDA, NIH, policy planners, cosmetologists, trichologists, players, athletes, dancers, wrestlers, equestrians, young women, aging population, toxicologists, environmental protectionists, pharmaceutical industry, biomedical scientists, researchers, medical students, physicians, nurses, paramedical professionals, and global audience will be interested in this interesting book to prevent pandemics and raise healthcare awareness.

chapter |77 pages

Introduction

chapter |2 pages

Concluding Remarks

part -1|56 pages

Charnolophagy

part -2|117 pages

Charnolophagy in Metabolic Disorders

chapter 7|18 pages

Charnolophagy in Congenital Diseases

chapter 9|16 pages

Charnolophagy in Malnutrition

chapter 10|6 pages

Charnolophagy in Diet Restriction

chapter 11|7 pages

Charnolophagy in Gastrointestinal Diseases

chapter 12|22 pages

Charnolophagy in Liver Diseases

chapter 13|11 pages

Charnolophagy in Diabetes

chapter 14|7 pages

Charnolophagy in Obesity

chapter 15|5 pages

Charnolophagy in Hyperlipidemia

part -3|143 pages

Charnolophagy in Systemic Disorders

chapter 16|11 pages

Charnolophagy in Skin and Hair Diseases

chapter 17|18 pages

Charnolophagy in Musculoskeletal Diseases

chapter 18|12 pages

Charnolophagy in Pulmonary Diseases

chapter 19|22 pages

Charnolophagy in Cardiovascular Diseases

chapter 20|5 pages

Charnolophagy in Renal Diseases

chapter 21|13 pages

Charnolophagy in Reproductive Diseases

chapter 22|9 pages

Charnolophagy in Ophthalmic Diseases

chapter 25|19 pages

Charnolophagy in Parkinson's Disease

chapter 26|7 pages

Charnolophagy in Alzheimer's Disease

chapter 27|6 pages

Charnolophagy in Stroke

part -4|126 pages

Charnolophagy in Inflammation, Cancer, Microbial Infections, and Aging

chapter 28|16 pages

Charnolophagy in Inflammatory Diseases

chapter 29|25 pages

Charnolophagy in Cancer (A)

chapter 30|26 pages

Charnolophagy in Cancer (B)

chapter 31|35 pages

Charnolophagy in Microbial Infections

chapter 32|22 pages

Charnolophagy in Aging

part -5|55 pages

Charnolophagy in Nanomedicine

chapter 33|40 pages

Charnolophagy in Nanotheranostics (Part-1)

chapter 34|13 pages

Charnolophagy in Nanotheranostics (Part-2)